MedComm: Senescence-based colorectal cancer subtyping guides therapy stratification
Jun 26, 2023
·
1 min read
Our team reported a MedComm study showing that senescence-related molecular programs can stratify colorectal cancer into clinically meaningful subtypes.
By integrating transcriptomic, genomic, digital pathology, and clinical data, the study linked senescence patterns to prognosis, tumor microenvironment states, and potential therapeutic opportunities.
Key points:
- Identified three senescence-related colorectal cancer subtypes with distinct biology and outcomes.
- Built a senescence score to support patient-level stratification in clinical settings.
- Suggested different treatment opportunities across chemotherapy, immunotherapy, and targeted therapy.